Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables

Darmstadt, Germany, July 12, 2016 — Merck, a leading science and technology company, has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand Merck’s excipients portfolio. Under the agreement, Merck will be the exclusive, global distributor of the Expansorb® line of biocompatible and biodegradable polymers.

More